The Cinch Annuloplasty Device is developed to provide a percutaneous, quick, safe and simple solution to a complex problem. It allows the tricuspid valve to function as it is intended and leaves a mimimal anatomic footprint. The Cinch Annuloplasty Device is designed and tested by experienced structural heart interventionalists and developed with the world-leading engineering team at Resolution Medical. IP is maintained through HOFFMANN EITLE. The tech has been developed through 3 years of testing and iterations based on test data and KOL user input including bench at Resolution Medical, beating heart model at LifeTec Group™ successful 10 minute In-vivo deployment in an animal modal at the pre-clinical reference lab at Veranex Preclinical Services, France (Formerly known as IMMR) in Paris with extremely encouraging results. The project has been supported by Haukeland universitetssjukehus, VIS - Vestlandets Innovasjonsselskap, Norges forskningsråd, GRIEG FOUNDATION and GC Rieber AS. Following our successful first-in-animal trial we are now aiming to expand our clinical and financial partnerships towards first-in-man device implantation.
